首页|期刊导航|肿瘤学创新(英文)|Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)OA

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)

Fei Ma;Binghe Xu

AKT inhibitorbreast cancerexpert consensushormone receptormTOR inhibitorPI3K inhibitor

AKT inhibitorbreast cancerexpert consensushormone receptormTOR inhibitorPI3K inhibitor

《肿瘤学创新(英文)》 2025 (3)

54-78,25

This study was funded by the Major Collaborative Innovation Project,Medical and Health Science and Technology Innovation Initiative,Chinese Academy of Medical Sciences(Project No.2021-I2M-1-014).

10.1002/cai2.70008

评论